MIRA
INFORM REPORT
|
Report Date : |
15.11.2007 |
IDENTIFICATION
DETAILS
|
Name : |
IWAKI KIZAI CO LTD |
|
|
|
|
Registered Office : |
5-3-1 Nagatanaka Higashiosaka Osaka-Pref 577-0013 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
Apr 1963 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import, wholesale of surgical
equipment & supplies |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Maximum Credit Limit : |
Yen 3.3 millions |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Regular |
name
IWAKI KIZAI CO LTD
REGD NAME
KK Iwaki Kizai
MAIN OFFICE
5-3-1 Nagatanaka Higashiosaka Osaka-Pref 577-0013 JAPAN
Tel : 06-6744-9472
Fax : 06-6744-9410
URL : http://www.iwaki-kizai.co.jp
E-Mail address: iwakimed@mocha.ocn.ne.jp
ACTIVITIES
Import, wholesale of surgical equipment & supplies
BRANCHES
Nil
OFFICERS
TOSHIO IWAKI, PRES
Yen Amount: In
million Yen, unless otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 180 M
PAYMENTS REGULAR CAPITAL Yen 10 M
TREND SLOW WORTH Yen 154 M
STARTED 1963 EMPLOYES 5
COMMENT
IMPORTER AND WHOLESALER SPECIALIZING IN MEDICAL SUPPLIES.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS
ENGAGEMENTS.
MAX CREDIT LIMIT: YEN 3.3 MILLION, 30 DAYS NORMAL
TERMS.
HIGHLIGHTS
The subject company was established by Toshio Iwaki in order to
make most of his experience in the subject line of business. This is a family-based trading firm
specializing in import and wholesale of surgical equipment & supplies,
centrally of orthopedics supplies.
Goods are imported from Germany and USA centrally as importing
agent. Clients are hospitals,
universities, clinics, medical instruments dealers, etc nationwide.
FINANCIAL INFORMATION
Financials are only partially disclosed.
The sales volume for Mar/2007 fiscal term amounted to Yen 180 million, a 3% down from Yen 185 million in the previous term. The net profit remained similar at Yen 8 million.
For the current term ending Mar 2008 the net profit is
projected at Yen 8 million, on a 3% recovery in turnover, to Yen 185 million. Business revived.
The financial situation is considered maintained FAIR and good
for ORDINARY business engagements. Max
credit limit is estimated at Yen 3.3 million, on 30 days normal terms.
REGISTRATION
Date Registered: Apr
1963
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 800
shares
Issued: 200
shares
Sum: Yen
10 million
Major shareholders (%): Toshio
Iwaki (100)
Nothing detrimental is known as to his commercial morality.
OPERATION
Activities: Imports and wholesales medical/surgical equipment
and supplies (--100%).
Goods are imported from Germany, USA, UK, other.
(Handling items): sterile
containers, washer disinfector, eye-care goods, plaster cast, gauze for
surgery, forceps, surgical knives, needle-holders, cleaning agents,
eye-shields, echo jelly, eye-droppers, others.
Clients: [Hospitals, clinics, medical instruments dealers] Konishi Medical Instruments, Miyano Medical Instruments, Yayoi Shokai, other.
No. of accounts: 300
Domestic areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Wagner, Lohmann Rencher,
Midicon, Duffner, Geomed (--Germany), Medtronic, Pharmaceutical (--USA), EMS,
Cameron Graham (--UK), Chin Kou Medical (Taiwan), other from Germany and USA
centrally.
Payment record: Regular
Location: Business area in Higashiosaka City. Office premises at the caption address are
leased and maintained satisfactorily.
Bank References
SMBC (Imazato)
MUFG (Imazato)
Relations: Satisfactory.
FINANCES
(In Million Yen)
|
Terms Ending: |
|
31/03/2008 |
31/03/2007 |
31/03/2006 |
31/03/2005 |
|
|
Annual
Sales |
|
185 |
180 |
185 |
190 |
|
|
Recur.
Profit |
|
|
|
|
|
|
|
Net
Profit |
|
8 |
8 |
8 |
10 |
|
|
Total
Assets |
|
|
N/A |
N/A |
N/A |
|
|
Net
Worth |
|
|
154 |
146 |
138 |
|
|
Capital,
Paid-Up |
|
|
10 |
10 |
10 |
|
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
||
|
S.Growth Rate |
2.78 |
-2.70 |
-2.63 |
-24.00 |
||
|
Current Ratio |
|
|
.. |
.. |
.. |
|
|
N.Worth Ratio |
|
.. |
.. |
.. |
||
|
N.Profit/Sales |
4.32 |
4.44 |
4.32 |
5.26 |
||
Note: Financials are only partially disclosed.
Forecast (or estimated) for the 31/03/2008 fiscal term.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)